鈴木 達也

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Biliary Atresia 56%
3. Living Donors 55%
4. Pediatrics 44%
5. Pharmacokinetics 30%
6. Aztreonam 27%
7. Liver 26%
8. Newborn Infant 24%
9. Serum 22%
10. Clinical Studies 22%
11. Hepatic Portoenterostomy 22%
12. Maple Syrup Urine Disease 21%
13. Choledochal Cyst 20%
14. Imipenem Drug Combination Cilastatin 20%
15. Premature Infants 19%
16. Cysts 18%
17. Bile 15%
18. Tissue Donors 15%
19. Transforming Growth Factors 14%
20. Complement C5a 14%
21. polyphyllin D 13%
22. Intravenous Infusions 13%
23. Transplants 13%
24. Japan 12%
25. Mowat-Wilson syndrome 12%
26. Bilirubin 12%
27. arctigenin 11%
28. biapenem 11%
29. Citrullinemia 11%
30. Cakut 11%
31. Progressive familial intrahepatic 1 Cholestasis 11%
32. Child 11%
33. Oxidative Stress 11%
34. Radiofrequency Therapy 10%
35. Sclerosing Cholangitis 10%
36. Bronchogenic Cyst 10%
37. Ovarian Teratoma 9%
38. Bronchopulmonary Sequestration 9%
39. Infections 9%
40. Rectal Fistula 9%
41. Funnel Chest 9%
42. Necroptosis 9%
43. Aspartate Aminotransferases 9%
44. Hepatoblastoma 9%
45. Obstructive Jaundice 9%
46. Human Herpesvirus 6 9%
47. Disorders of Sex Development 9%
48. Tazobactam Drug Combination Piperacillin 8%
49. Herpesviridae Infections 8%
50. Calcium-Calmodulin-Dependent Protein Kinase Type 2 8%